{"id":"W4379794089","doi":"10.1136/annrheumdis-2023-eular.833","title":"POS1106 ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"BASDAI; Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Placebo; Physical therapy; Disease; Gastroenterology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001983702,0.0009104039,0.001954202,0.0003133164,0.000335259,0.001076981,0.0005357948,0.001328223,0.00221916],"category_scores_gemma":[0.001560512,0.000439884,0.001948133,0.0004382762,0.0006466407,0.0008382873,0.0003485815,0.002403961,0.0006224634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005125304,"about_ca_system_score_gemma":0.0008320058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008130733,"about_ca_topic_score_gemma":0.001602482,"domain_scores_codex":[0.9990277,0.0005536089,0.00006097772,0.000107506,0.0001158836,0.0001342803],"domain_scores_gemma":[0.9987774,0.0003789384,0.0003796642,0.00006385057,0.00008272806,0.0003173378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8565245,0.00945417,0.02499065,0.001100512,0.002441456,0.0001463177,0.0001830974,0.0009158718,0.01105463,0.0001630549,0.002531917,0.09049378],"study_design_scores_gemma":[0.4360961,0.4153217,0.1383087,0.000210832,0.00233567,0.000550726,0.0001952288,0.0009823368,0.002283778,0.0002647409,0.003354861,0.00009538484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905531,0.00604652,0.0001628857,0.0004056749,0.000113541,0.0002687302,0.0009495108,0.00003595615,0.001464141],"genre_scores_gemma":[0.9941234,0.002294991,0.0003762779,0.0005679881,0.0001209944,0.0002903718,0.001513682,0.00001547382,0.0006968401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00221916,"threshold_uncertainty_score":0.01049095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03783609211465162,"score_gpt":0.3305978437230427,"score_spread":0.2927617516083911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}